Back to search

Virginia Commonwealth University

Levofloxacin Incorporated Extracellular Matrix Nanoparticles for Pulmonary Cystic Fibrosis Infections

Abstract

dc:description.abstract

Cystic fibrosis (CF) is a progressive genetic disorder that affects around 40,000 people in the United States. CF is characterized by a mutation in the CFTR protein that causes dysregulated ion transport across epithelial cells, producing viscous mucus in the lung that increases bacterial invasion, causing persistent infections and subsequent inflammation. Pseudomonas aeruginosa and Staphylococcus aureus are two of the most common infections in CF patients that are resistant to antibiotics. One antibiotic approved to treat these infections is levofloxacin (LVX) that functions to inhibit bacterial replication, but can be further developed into tailorable particles. Nanoparticles are an emerging inhaled therapeutic made for enhanced targeting and delivery to specific lung structures. Previously, porcine lung extracellular matrix (PL-ECM) nanoparticles (NPs) have demonstrated pro-regenerative and non-toxic effects in vitro, capable of targeting the lower respiratory tract. However, CF mucus presents a barrier to inhaled therapeutics by size and interaction filtering. We hypothesize that the combination of LVX with PL-ECM, formed into nanoparticles with suitable size and charge, will be able to target CF bacterial infections by penetrating through the mucus. Two hybrid formulations of a 10:1 and 1:1 ratio of LVX to ECM have shown neutral surface charges and an average size of ~525 nm and ~300 nm, respectively. The NPs have also shown the ability to penetrate through CF mucus and slowed drug dissolution. The NPs have also shown to be non-toxic to human airway epithelial cells and are effective in inhibiting P. aeruginosa and S. aureus.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Biomedical Engineering

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Patel, Raahi
Contributors dc:contributor
  • Rebecca Heise
  • Masahiro Sakagami
  • Christopher Lemmon

Subjects

dc:subject × 8

Rights

dc:rights
Statement dc:rights
  • © Raahi Patel

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Patel, Raahi. Levofloxacin Incorporated Extracellular Matrix Nanoparticles for Pulmonary Cystic Fibrosis Infections. Thesis thesis, https://doi.org/10.25772/0SPZ-KR29